Results 11 to 20 of about 43,956 (290)

Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity

JAMA pediatrics, 2021
Key Points Question Does enteral fatty acid supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) from birth to 40 weeks’ postmenstrual age reduce severe retinopathy of prematurity (ROP) in extremely preterm infants?
A. Hellström, A. Nilsson, D. Wackernagel, A. Pivodic, M. Vanpee, Ulrika Sjöbom, G. Hellgren, B. Hallberg, M. Domellöf, Susanna Klevebro, William Hellström, M. Andersson, Anna-My Lund, Chatarina Löfqvist, A. Elfvin, K. Sävman, I. Hansen-Pupp, A. Hård, Lois E. H. Smith, D. Ley   +19 more
semanticscholar   +1 more source

Retinopathy of Prematurity among Preterm Newborn Admitted to the Neonatal Care Unit in a Tertiary Care Centre: A Descriptive Cross-sectional Study

Journal of Nepal Medical Association, 2023
Introduction: World Health Organization has identified retinopathy of prematurity as an important cause of preventable childhood blindness. The presentation of retinopathy of prematurity is varied and differs in the developed and developing worlds.
Pradeep Bastola, Swapnil Madhukar Parchand, Anil Babanrao Gangwe, Sheeksha Bastola, Deepshikha Agrawal   +4 more
doaj   +1 more source

80 Years of vision: preventing blindness from retinopathy of prematurity

Journal of Perinatology, 2021
Retinopathy of prematurity (ROP) is one of the leading yet preventable causes of childhood blindness worldwide. The purpose of this review is to provide a practical template for observational and treatment methods in order to reduce the overall incidence
E. H. Wood, E. Chang, Kinley D. Beck, Brandon R. Hadfield, Amy R. Quinn, C. Harper   +5 more
semanticscholar   +1 more source

Pathophysiology of retinopathy of prematurity

Saudi Journal of Ophthalmology, 2022
Retinopathy of prematurity (ROP) is a vasoproliferative disease occurring in premature infants that affects the blood vessels of the developing retina.
Y. N. Strube, K. Wright
semanticscholar   +1 more source

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants

JAMA Network Open, 2021
This cohort study evaluates the association of long-chain polyunsaturated fatty acid serum levels with the development of retinopathy of prematurity in extremely preterm infants.
A. Hellström, A. Pivodic, Lotta Gränse, Pia Lundgren, Ulrika Sjöbom, A. Nilsson, Helena Söderling, A. Hård, Lois E. H. Smith, Chatarina Löfqvist   +9 more
semanticscholar   +1 more source

Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies

International Journal of Molecular Sciences, 2021
Retinopathy of prematurity (ROP) is an ocular vascular disease affecting premature infants, characterized by pathological retinal neovascularization (RNV), dilated and tortuous retinal blood vessels, and retinal or vitreous hemorrhages that may lead to ...
Chang Dai, K. Webster, Amit R. Bhatt, H. Tian, Guanfang Su, Wei Li   +5 more
semanticscholar   +1 more source

Effects of Adjuvant Administration of Macromolecules and Total Calories through Aggressive Parenteral Nutrition in Improvement of Neovascularisation of Infants with Retinopathy of Prematurity: A Literature Review

Scripta Score Scientific Medical Journal, 2022
Introduction: Retinopathy of Prematurity (ROP) is almost exclusively in premature infants. With advanced care and technology, the prevalence of retinopathy of prematurity in babies is increasing, which means the incidence of preventable blindness in ROP ...
Stefany Tanto, Gilbert Sterling Octavius, Alvita Suci Edgina   +2 more
doaj   +1 more source

The Role of Retinopathy Anemia in the Pathogenesis of Retinopathy of Prematurity and the Effect of Erythropoietin Treatment on the Frequency and Severity of the Disease

Oftalʹmologiâ, 2020
Premature infants with extremely low birth weight are at high risk of developing severe disabling forms of retinopathy of prematurity. Nonsurgical therapy methods of treatment of retinopathy in prematurity are  ineffective.
V. I. Lebedev, L. A. Katargina
doaj   +1 more source

Ranibizumab in retinopathy of prematurity – one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study

Acta ophthalmologica, 2021
The primary endpoint results from the comparing alternative ranibizumab dosages for safety and efficacy in retinopathy of prematurity (CARE‐ROP) core study identified ranibizumab as an effective treatment to control acute retinopathy of prematurity (ROP).
A. Stahl, Marie-Christine Bründer, W. Lagrèze, Fanni E Molnár, T. Barth, N. Eter, R. Guthoff, T. Krohne, J. Pfeil   +8 more
semanticscholar   +1 more source

The prenatal phase of retinopathy of prematurity

Acta paediatrica, 2021
To explore the current literature on prenatal inflammation‐associated risk factors for retinopathy of prematurity (ROP).
O. Dammann, J. Rivera, S. Chemtob
semanticscholar   +1 more source